{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Preprocess and tokenize the article text from the dataframe of the 4 companies to fix the date format issue."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import pickle"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_text</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>Apr 01, 2019</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Acquisition will give Novartis one clinical an...</td>\n",
       "      <td>Novartis adds clinical and preclinical anti-in...</td>\n",
       "      <td>NVS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1</td>\n",
       "      <td>Jun 15, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Cosentyx® is the first and only IL-17A inhibit...</td>\n",
       "      <td>Novartis' Cosentyx shows sustained improvement...</td>\n",
       "      <td>NVS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2</td>\n",
       "      <td>Jun 04, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Study is longest follow-up to date of a BRAF a...</td>\n",
       "      <td>Novartis landmark study of Tafinlar® + Mekinis...</td>\n",
       "      <td>NVS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>3</td>\n",
       "      <td>Apr 30, 2019</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/s...</td>\n",
       "      <td>Collaboration covers proposed trastuzumab bios...</td>\n",
       "      <td>Sandoz enters agreement for proposed trastuzum...</td>\n",
       "      <td>NVS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>4</td>\n",
       "      <td>Jun 23, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>83% of patients achieved complete remission (C...</td>\n",
       "      <td>Novartis pivotal CTL019 6-month follow-up data...</td>\n",
       "      <td>NVS</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   article_date                                  article_link-href  \\\n",
       "0  Apr 01, 2019  https://www.novartis.com/news/media-releases/n...   \n",
       "1  Jun 15, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "2  Jun 04, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "3  Apr 30, 2019  https://www.novartis.com/news/media-releases/s...   \n",
       "4  Jun 23, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "\n",
       "                                        article_text  \\\n",
       "0  Acquisition will give Novartis one clinical an...   \n",
       "1  Cosentyx® is the first and only IL-17A inhibit...   \n",
       "2  Study is longest follow-up to date of a BRAF a...   \n",
       "3  Collaboration covers proposed trastuzumab bios...   \n",
       "4  83% of patients achieved complete remission (C...   \n",
       "\n",
       "                                       article_title ticker  \n",
       "0  Novartis adds clinical and preclinical anti-in...    NVS  \n",
       "1  Novartis' Cosentyx shows sustained improvement...    NVS  \n",
       "2  Novartis landmark study of Tafinlar® + Mekinis...    NVS  \n",
       "3  Sandoz enters agreement for proposed trastuzum...    NVS  \n",
       "4  Novartis pivotal CTL019 6-month follow-up data...    NVS  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "with open('df_4_companies_prep.pickle', 'rb') as read_file:\n",
    "    df_4_companies_prep=pickle.load(read_file)\n",
    "df_4_companies_prep.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Looks good. Need to make the article_text lowercase, remove punctuation, numbers, nonsense text, then tokenize."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "import string\n",
    "from pprint import pprint\n",
    "import nltk\n",
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from sklearn.decomposition import TruncatedSVD\n",
    "from sklearn.decomposition import NMF\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "#import gensim\n",
    "#import gensim.corpora as corpora\n",
    "#from gensim.utils import simple_preprocess\n",
    "#from gensim.models import CoherenceModel\n",
    "#import spacy\n",
    "import matplotlib.pyplot as plt\n",
    "%matplotlib inline\n",
    "###need to figure out the gensim problem. It can't find the module"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "alphanumeric = lambda x: re.sub('\\w*\\d\\w*', ' ', x)\n",
    "punc_lower = lambda x: re.sub('[%s]' % re.escape(string.punctuation), ' ', x.lower())\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_text</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_lower</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>Apr 01, 2019</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Acquisition will give Novartis one clinical an...</td>\n",
       "      <td>Novartis adds clinical and preclinical anti-in...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>acquisition will give novartis one clinical an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1</td>\n",
       "      <td>Jun 15, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Cosentyx® is the first and only IL-17A inhibit...</td>\n",
       "      <td>Novartis' Cosentyx shows sustained improvement...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>cosentyx® is the first and only il   inhibitor...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2</td>\n",
       "      <td>Jun 04, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Study is longest follow-up to date of a BRAF a...</td>\n",
       "      <td>Novartis landmark study of Tafinlar® + Mekinis...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>study is longest follow up to date of a braf a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>3</td>\n",
       "      <td>Apr 30, 2019</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/s...</td>\n",
       "      <td>Collaboration covers proposed trastuzumab bios...</td>\n",
       "      <td>Sandoz enters agreement for proposed trastuzum...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>collaboration covers proposed trastuzumab bios...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>4</td>\n",
       "      <td>Jun 23, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>83% of patients achieved complete remission (C...</td>\n",
       "      <td>Novartis pivotal CTL019 6-month follow-up data...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>of patients achieved complete remission  cr...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   article_date                                  article_link-href  \\\n",
       "0  Apr 01, 2019  https://www.novartis.com/news/media-releases/n...   \n",
       "1  Jun 15, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "2  Jun 04, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "3  Apr 30, 2019  https://www.novartis.com/news/media-releases/s...   \n",
       "4  Jun 23, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "\n",
       "                                        article_text  \\\n",
       "0  Acquisition will give Novartis one clinical an...   \n",
       "1  Cosentyx® is the first and only IL-17A inhibit...   \n",
       "2  Study is longest follow-up to date of a BRAF a...   \n",
       "3  Collaboration covers proposed trastuzumab bios...   \n",
       "4  83% of patients achieved complete remission (C...   \n",
       "\n",
       "                                       article_title ticker  \\\n",
       "0  Novartis adds clinical and preclinical anti-in...    NVS   \n",
       "1  Novartis' Cosentyx shows sustained improvement...    NVS   \n",
       "2  Novartis landmark study of Tafinlar® + Mekinis...    NVS   \n",
       "3  Sandoz enters agreement for proposed trastuzum...    NVS   \n",
       "4  Novartis pivotal CTL019 6-month follow-up data...    NVS   \n",
       "\n",
       "                                  article_text_lower  \n",
       "0  acquisition will give novartis one clinical an...  \n",
       "1  cosentyx® is the first and only il   inhibitor...  \n",
       "2  study is longest follow up to date of a braf a...  \n",
       "3  collaboration covers proposed trastuzumab bios...  \n",
       "4     of patients achieved complete remission  cr...  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_4_companies_prep['article_text_lower']=df_4_companies_prep.article_text.map(alphanumeric).map(punc_lower)\n",
    "df_4_companies_prep.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_text</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_lower</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>1254</td>\n",
       "      <td>March 16, 2019</td>\n",
       "      <td>http://ir.clovisoncology.com/investors-and-new...</td>\n",
       "      <td>Exploratory analyses of ARIEL3 Rubraca data in...</td>\n",
       "      <td>Clovis Oncology to Highlight Rubraca® (rucapar...</td>\n",
       "      <td>CLVS</td>\n",
       "      <td>exploratory analyses of   rubraca data in recu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1255</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td>http://ir.clovisoncology.com/investors-and-new...</td>\n",
       "      <td>Rubraca\\n    \\n      ®\\n    \\n     (rucaparib)...</td>\n",
       "      <td>Clovis Oncology Announces European Commission ...</td>\n",
       "      <td>CLVS</td>\n",
       "      <td>rubraca\\n    \\n      ®\\n    \\n      rucaparib ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1256</td>\n",
       "      <td>June 06, 2019</td>\n",
       "      <td>http://ir.clovisoncology.com/investors-and-new...</td>\n",
       "      <td>Dr. M. James Barrett, Chair since inception, r...</td>\n",
       "      <td>Clovis Oncology Names Ginger L. Graham as New ...</td>\n",
       "      <td>CLVS</td>\n",
       "      <td>dr  m  james barrett  chair since inception  r...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1257</td>\n",
       "      <td>August 22, 2019</td>\n",
       "      <td>http://ir.clovisoncology.com/investors-and-new...</td>\n",
       "      <td>BOULDER, Colo.--(BUSINESS WIRE)--\\nClovis Onco...</td>\n",
       "      <td>Clovis Oncology Announces Exercise by Initial ...</td>\n",
       "      <td>CLVS</td>\n",
       "      <td>boulder  colo    business wire   \\nclovis onco...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1258</td>\n",
       "      <td>May 06, 2019</td>\n",
       "      <td>http://ir.clovisoncology.com/investors-and-new...</td>\n",
       "      <td>BOULDER, Colo.--(BUSINESS WIRE)--\\n      Clovi...</td>\n",
       "      <td>Clovis Oncology to Present at the Bank of Amer...</td>\n",
       "      <td>CLVS</td>\n",
       "      <td>boulder  colo    business wire   \\n      clovi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1259</td>\n",
       "      <td>March 19, 2019</td>\n",
       "      <td>http://ir.clovisoncology.com/investors-and-new...</td>\n",
       "      <td>Accepted abstracts highlight data from a phase...</td>\n",
       "      <td>Clovis Oncology Announces Presentations at 201...</td>\n",
       "      <td>CLVS</td>\n",
       "      <td>accepted abstracts highlight data from a phase...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1260</td>\n",
       "      <td>April 02, 2019</td>\n",
       "      <td>http://ir.clovisoncology.com/investors-and-new...</td>\n",
       "      <td>Interim data from an investigator-initiated st...</td>\n",
       "      <td>Clovis Oncology Announces Interim Results from...</td>\n",
       "      <td>CLVS</td>\n",
       "      <td>interim data from an investigator initiated st...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1261</td>\n",
       "      <td>January 02, 2019</td>\n",
       "      <td>http://ir.clovisoncology.com/investors-and-new...</td>\n",
       "      <td>BOULDER, Colo.--(BUSINESS WIRE)--\\n      Clovi...</td>\n",
       "      <td>Clovis Oncology to Present at the 37th Annual ...</td>\n",
       "      <td>CLVS</td>\n",
       "      <td>boulder  colo    business wire   \\n      clovi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1262</td>\n",
       "      <td>December 16, 2019</td>\n",
       "      <td>http://ir.clovisoncology.com/investors-and-new...</td>\n",
       "      <td>Presented at the International Symposium on Th...</td>\n",
       "      <td>Initial Clinical Experience Reported from FAP-...</td>\n",
       "      <td>CLVS</td>\n",
       "      <td>presented at the international symposium on th...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1263</td>\n",
       "      <td>February 19, 2019</td>\n",
       "      <td>http://ir.clovisoncology.com/investors-and-new...</td>\n",
       "      <td>-- Combinations of ALKS 4230 with Rucaparib an...</td>\n",
       "      <td>Alkermes and Clovis Oncology Initiate Research...</td>\n",
       "      <td>CLVS</td>\n",
       "      <td>combinations of alks   with rucaparib and l...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           article_date                                  article_link-href  \\\n",
       "1254     March 16, 2019  http://ir.clovisoncology.com/investors-and-new...   \n",
       "1255   January 24, 2019  http://ir.clovisoncology.com/investors-and-new...   \n",
       "1256      June 06, 2019  http://ir.clovisoncology.com/investors-and-new...   \n",
       "1257    August 22, 2019  http://ir.clovisoncology.com/investors-and-new...   \n",
       "1258       May 06, 2019  http://ir.clovisoncology.com/investors-and-new...   \n",
       "1259     March 19, 2019  http://ir.clovisoncology.com/investors-and-new...   \n",
       "1260     April 02, 2019  http://ir.clovisoncology.com/investors-and-new...   \n",
       "1261   January 02, 2019  http://ir.clovisoncology.com/investors-and-new...   \n",
       "1262  December 16, 2019  http://ir.clovisoncology.com/investors-and-new...   \n",
       "1263  February 19, 2019  http://ir.clovisoncology.com/investors-and-new...   \n",
       "\n",
       "                                           article_text  \\\n",
       "1254  Exploratory analyses of ARIEL3 Rubraca data in...   \n",
       "1255  Rubraca\\n    \\n      ®\\n    \\n     (rucaparib)...   \n",
       "1256  Dr. M. James Barrett, Chair since inception, r...   \n",
       "1257  BOULDER, Colo.--(BUSINESS WIRE)--\\nClovis Onco...   \n",
       "1258  BOULDER, Colo.--(BUSINESS WIRE)--\\n      Clovi...   \n",
       "1259  Accepted abstracts highlight data from a phase...   \n",
       "1260  Interim data from an investigator-initiated st...   \n",
       "1261  BOULDER, Colo.--(BUSINESS WIRE)--\\n      Clovi...   \n",
       "1262  Presented at the International Symposium on Th...   \n",
       "1263  -- Combinations of ALKS 4230 with Rucaparib an...   \n",
       "\n",
       "                                          article_title ticker  \\\n",
       "1254  Clovis Oncology to Highlight Rubraca® (rucapar...   CLVS   \n",
       "1255  Clovis Oncology Announces European Commission ...   CLVS   \n",
       "1256  Clovis Oncology Names Ginger L. Graham as New ...   CLVS   \n",
       "1257  Clovis Oncology Announces Exercise by Initial ...   CLVS   \n",
       "1258  Clovis Oncology to Present at the Bank of Amer...   CLVS   \n",
       "1259  Clovis Oncology Announces Presentations at 201...   CLVS   \n",
       "1260  Clovis Oncology Announces Interim Results from...   CLVS   \n",
       "1261  Clovis Oncology to Present at the 37th Annual ...   CLVS   \n",
       "1262  Initial Clinical Experience Reported from FAP-...   CLVS   \n",
       "1263  Alkermes and Clovis Oncology Initiate Research...   CLVS   \n",
       "\n",
       "                                     article_text_lower  \n",
       "1254  exploratory analyses of   rubraca data in recu...  \n",
       "1255  rubraca\\n    \\n      ®\\n    \\n      rucaparib ...  \n",
       "1256  dr  m  james barrett  chair since inception  r...  \n",
       "1257  boulder  colo    business wire   \\nclovis onco...  \n",
       "1258  boulder  colo    business wire   \\n      clovi...  \n",
       "1259  accepted abstracts highlight data from a phase...  \n",
       "1260  interim data from an investigator initiated st...  \n",
       "1261  boulder  colo    business wire   \\n      clovi...  \n",
       "1262  presented at the international symposium on th...  \n",
       "1263     combinations of alks   with rucaparib and l...  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#I think it worked. \n",
    "df_4_companies_prep.tail(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "#df_4_companies_prep.at[1, 'article_text_lower']"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Numbers are gone and everything is lowercase. There are still quotation marks, and nonsense characters. Also I'm wondering if I should remove the \"about\" and \"forward-looking statements\" from each company's press releases. That might reduce the noise.\n",
    "Maybe I could do TF-IDF within each company to reduce the noise from the repeated about and forward-looking statements."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Can I take out \"this press release includes forward looking statements \" and everything after?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: textblob in /Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages (0.15.3)\n",
      "Requirement already satisfied: nltk>=3.1 in /Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages (from textblob) (3.5)\n",
      "Requirement already satisfied: click in /Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages (from nltk>=3.1->textblob) (7.1.2)\n",
      "Requirement already satisfied: tqdm in /Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages (from nltk>=3.1->textblob) (4.57.0)\n",
      "Requirement already satisfied: regex in /Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages (from nltk>=3.1->textblob) (2021.3.17)\n",
      "Requirement already satisfied: joblib in /Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages (from nltk>=3.1->textblob) (1.0.1)\n"
     ]
    }
   ],
   "source": [
    "!pip install textblob"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys\n",
    "sys.path.append(\"/Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "from textblob import TextBlob"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package stopwords to\n",
      "[nltk_data]     /Users/amysillman/nltk_data...\n",
      "[nltk_data]   Package stopwords is already up-to-date!\n"
     ]
    }
   ],
   "source": [
    "from nltk.corpus import stopwords\n",
    "nltk.download('stopwords')\n",
    "from nltk.tokenize import word_tokenize\n",
    "stop=stopwords.words('english')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package punkt to\n",
      "[nltk_data]     /Users/amysillman/nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nltk.download('punkt')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "#remove nonsense text. This is from stackoverflow \n",
    "#https://stackoverflow.com/questions/52787309/removing-nonsense-words-in-python\n",
    "\n",
    "words = set(nltk.corpus.words.words())\n",
    "\n",
    "def clean_sent(sent):\n",
    "    return \" \".join(w for w in nltk.wordpunct_tokenize(sent) \\\n",
    "     if w.lower() in words or not w.isalpha())\n",
    "\n",
    "df_4_companies_prep['article_text_clean'] = df_4_companies_prep['article_text_lower'].apply(clean_sent)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_text</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_lower</th>\n",
       "      <th>article_text_clean</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>Apr 01, 2019</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Acquisition will give Novartis one clinical an...</td>\n",
       "      <td>Novartis adds clinical and preclinical anti-in...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>acquisition will give novartis one clinical an...</td>\n",
       "      <td>acquisition will give one clinical and two pre...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1</td>\n",
       "      <td>Jun 15, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Cosentyx® is the first and only IL-17A inhibit...</td>\n",
       "      <td>Novartis' Cosentyx shows sustained improvement...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>cosentyx® is the first and only il   inhibitor...</td>\n",
       "      <td>® is the first and only inhibitor to show sust...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2</td>\n",
       "      <td>Jun 04, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Study is longest follow-up to date of a BRAF a...</td>\n",
       "      <td>Novartis landmark study of Tafinlar® + Mekinis...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>study is longest follow up to date of a braf a...</td>\n",
       "      <td>study is follow up to date of a and inhibitor ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>3</td>\n",
       "      <td>Apr 30, 2019</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/s...</td>\n",
       "      <td>Collaboration covers proposed trastuzumab bios...</td>\n",
       "      <td>Sandoz enters agreement for proposed trastuzum...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>collaboration covers proposed trastuzumab bios...</td>\n",
       "      <td>collaboration in phase development for human e...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>4</td>\n",
       "      <td>Jun 23, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>83% of patients achieved complete remission (C...</td>\n",
       "      <td>Novartis pivotal CTL019 6-month follow-up data...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>of patients achieved complete remission  cr...</td>\n",
       "      <td>of complete remission or with incomplete blood...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>5</td>\n",
       "      <td>May 25, 2016</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Outlines actions underway to accelerate launch...</td>\n",
       "      <td>Novartis highlights its strong foundation for ...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>outlines actions underway to accelerate launch...</td>\n",
       "      <td>underway to accelerate launch of ® further exp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>6</td>\n",
       "      <td>Nov 05, 2018</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>26 potential blockbusters in confirmatory deve...</td>\n",
       "      <td>Novartis R&amp;D update highlights industry leadin...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>potential blockbusters in confirmatory devel...</td>\n",
       "      <td>potential in confirmatory development in clini...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>7</td>\n",
       "      <td>May 01, 2018</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/k...</td>\n",
       "      <td>Kymriah demonstrated an overall response rate ...</td>\n",
       "      <td>Kymriah® (tisagenlecleucel), first-in-class CA...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>kymriah demonstrated an overall response rate ...</td>\n",
       "      <td>an overall response rate of with median durati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>8</td>\n",
       "      <td>Jun 28, 2016</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Agreement is the latest in a series of acquisi...</td>\n",
       "      <td>Novartis adds bispecific antibodies to its gro...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>agreement is the latest in a series of acquisi...</td>\n",
       "      <td>agreement is the latest in a series of and str...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>9</td>\n",
       "      <td>Jan 22, 2018</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>LIBERTY is the first migraine prevention trial...</td>\n",
       "      <td>Novartis reports erenumab met all primary and ...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>liberty is the first migraine prevention trial...</td>\n",
       "      <td>liberty is the first migraine prevention trial...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   article_date                                  article_link-href  \\\n",
       "0  Apr 01, 2019  https://www.novartis.com/news/media-releases/n...   \n",
       "1  Jun 15, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "2  Jun 04, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "3  Apr 30, 2019  https://www.novartis.com/news/media-releases/s...   \n",
       "4  Jun 23, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "5  May 25, 2016  https://www.novartis.com/news/media-releases/n...   \n",
       "6  Nov 05, 2018  https://www.novartis.com/news/media-releases/n...   \n",
       "7  May 01, 2018  https://www.novartis.com/news/media-releases/k...   \n",
       "8  Jun 28, 2016  https://www.novartis.com/news/media-releases/n...   \n",
       "9  Jan 22, 2018  https://www.novartis.com/news/media-releases/n...   \n",
       "\n",
       "                                        article_text  \\\n",
       "0  Acquisition will give Novartis one clinical an...   \n",
       "1  Cosentyx® is the first and only IL-17A inhibit...   \n",
       "2  Study is longest follow-up to date of a BRAF a...   \n",
       "3  Collaboration covers proposed trastuzumab bios...   \n",
       "4  83% of patients achieved complete remission (C...   \n",
       "5  Outlines actions underway to accelerate launch...   \n",
       "6  26 potential blockbusters in confirmatory deve...   \n",
       "7  Kymriah demonstrated an overall response rate ...   \n",
       "8  Agreement is the latest in a series of acquisi...   \n",
       "9  LIBERTY is the first migraine prevention trial...   \n",
       "\n",
       "                                       article_title ticker  \\\n",
       "0  Novartis adds clinical and preclinical anti-in...    NVS   \n",
       "1  Novartis' Cosentyx shows sustained improvement...    NVS   \n",
       "2  Novartis landmark study of Tafinlar® + Mekinis...    NVS   \n",
       "3  Sandoz enters agreement for proposed trastuzum...    NVS   \n",
       "4  Novartis pivotal CTL019 6-month follow-up data...    NVS   \n",
       "5  Novartis highlights its strong foundation for ...    NVS   \n",
       "6  Novartis R&D update highlights industry leadin...    NVS   \n",
       "7  Kymriah® (tisagenlecleucel), first-in-class CA...    NVS   \n",
       "8  Novartis adds bispecific antibodies to its gro...    NVS   \n",
       "9  Novartis reports erenumab met all primary and ...    NVS   \n",
       "\n",
       "                                  article_text_lower  \\\n",
       "0  acquisition will give novartis one clinical an...   \n",
       "1  cosentyx® is the first and only il   inhibitor...   \n",
       "2  study is longest follow up to date of a braf a...   \n",
       "3  collaboration covers proposed trastuzumab bios...   \n",
       "4     of patients achieved complete remission  cr...   \n",
       "5  outlines actions underway to accelerate launch...   \n",
       "6    potential blockbusters in confirmatory devel...   \n",
       "7  kymriah demonstrated an overall response rate ...   \n",
       "8  agreement is the latest in a series of acquisi...   \n",
       "9  liberty is the first migraine prevention trial...   \n",
       "\n",
       "                                  article_text_clean  \n",
       "0  acquisition will give one clinical and two pre...  \n",
       "1  ® is the first and only inhibitor to show sust...  \n",
       "2  study is follow up to date of a and inhibitor ...  \n",
       "3  collaboration in phase development for human e...  \n",
       "4  of complete remission or with incomplete blood...  \n",
       "5  underway to accelerate launch of ® further exp...  \n",
       "6  potential in confirmatory development in clini...  \n",
       "7  an overall response rate of with median durati...  \n",
       "8  agreement is the latest in a series of and str...  \n",
       "9  liberty is the first migraine prevention trial...  "
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_4_companies_prep.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "#nonsense text seems to be gone\n",
    "#df_4_companies_prep.at[1, 'article_text_clean']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Pickle this dataframe and save as csv. It contains the raw article text, the article text w numbers \n",
    "#removed and all lowercase letters, and the text cleaned of nonsense words. I changed\n",
    "#the filenames of the previous csv and pickle files by appending _old\n",
    "df_4_companies_prep.to_csv('df_4_companies_prep.csv')\n",
    "with open('df_4_companies_prep.pickle', 'wb') as to_write:\n",
    "    pickle.dump(df_4_companies_prep, to_write)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Let's drop a couple columns that we no longer need.\n",
    "df_4_companies_prep.drop(columns=['article_text', 'article_text_lower'], inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_clean</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>Apr 01, 2019</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Novartis adds clinical and preclinical anti-in...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>acquisition will give one clinical and two pre...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   article_date                                  article_link-href  \\\n",
       "0  Apr 01, 2019  https://www.novartis.com/news/media-releases/n...   \n",
       "\n",
       "                                       article_title ticker  \\\n",
       "0  Novartis adds clinical and preclinical anti-in...    NVS   \n",
       "\n",
       "                                  article_text_clean  \n",
       "0  acquisition will give one clinical and two pre...  "
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_4_companies_prep.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "##NOT DOING THIS AGAIN\n",
    "#Tokenize into trigrams \n",
    "from nltk.util import ngrams\n",
    "from nltk.tokenize import word_tokenize"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "#First, tokenize by words\n",
    "df_4_companies_prep['article_text_words']=df_4_companies_prep['article_text_clean'].apply(word_tokenize)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_clean</th>\n",
       "      <th>article_text_words</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>Apr 01, 2019</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Novartis adds clinical and preclinical anti-in...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>acquisition will give one clinical and two pre...</td>\n",
       "      <td>[acquisition, will, give, one, clinical, and, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1</td>\n",
       "      <td>Jun 15, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Novartis' Cosentyx shows sustained improvement...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>® is the first and only inhibitor to show sust...</td>\n",
       "      <td>[®, is, the, first, and, only, inhibitor, to, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2</td>\n",
       "      <td>Jun 04, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Novartis landmark study of Tafinlar® + Mekinis...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>study is follow up to date of a and inhibitor ...</td>\n",
       "      <td>[study, is, follow, up, to, date, of, a, and, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>3</td>\n",
       "      <td>Apr 30, 2019</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/s...</td>\n",
       "      <td>Sandoz enters agreement for proposed trastuzum...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>collaboration in phase development for human e...</td>\n",
       "      <td>[collaboration, in, phase, development, for, h...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>4</td>\n",
       "      <td>Jun 23, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Novartis pivotal CTL019 6-month follow-up data...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>of complete remission or with incomplete blood...</td>\n",
       "      <td>[of, complete, remission, or, with, incomplete...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   article_date                                  article_link-href  \\\n",
       "0  Apr 01, 2019  https://www.novartis.com/news/media-releases/n...   \n",
       "1  Jun 15, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "2  Jun 04, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "3  Apr 30, 2019  https://www.novartis.com/news/media-releases/s...   \n",
       "4  Jun 23, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "\n",
       "                                       article_title ticker  \\\n",
       "0  Novartis adds clinical and preclinical anti-in...    NVS   \n",
       "1  Novartis' Cosentyx shows sustained improvement...    NVS   \n",
       "2  Novartis landmark study of Tafinlar® + Mekinis...    NVS   \n",
       "3  Sandoz enters agreement for proposed trastuzum...    NVS   \n",
       "4  Novartis pivotal CTL019 6-month follow-up data...    NVS   \n",
       "\n",
       "                                  article_text_clean  \\\n",
       "0  acquisition will give one clinical and two pre...   \n",
       "1  ® is the first and only inhibitor to show sust...   \n",
       "2  study is follow up to date of a and inhibitor ...   \n",
       "3  collaboration in phase development for human e...   \n",
       "4  of complete remission or with incomplete blood...   \n",
       "\n",
       "                                  article_text_words  \n",
       "0  [acquisition, will, give, one, clinical, and, ...  \n",
       "1  [®, is, the, first, and, only, inhibitor, to, ...  \n",
       "2  [study, is, follow, up, to, date, of, a, and, ...  \n",
       "3  [collaboration, in, phase, development, for, h...  \n",
       "4  [of, complete, remission, or, with, incomplete...  "
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_4_companies_prep.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_clean</th>\n",
       "      <th>article_text_words</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>September 15, 2016 at 7:30 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>New Data Presented at ECTRIMS Reinforce Effica...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>new analysis of “ no evidence of disease activ...</td>\n",
       "      <td>[new, analysis, of, “, no, evidence, of, disea...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        article_date  \\\n",
       "0  September 15, 2016 at 7:30 AM EDT   \n",
       "\n",
       "                                   article_link-href  \\\n",
       "0  https://investors.biogen.com/news-releases/new...   \n",
       "\n",
       "                                       article_title ticker  \\\n",
       "0  New Data Presented at ECTRIMS Reinforce Effica...   BIIB   \n",
       "\n",
       "                                  article_text_clean  \\\n",
       "0  new analysis of “ no evidence of disease activ...   \n",
       "\n",
       "                                  article_text_words  \n",
       "0  [new, analysis, of, “, no, evidence, of, disea...  "
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_9_companies_prep.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "###for 4 companies notebook, not doing this\n",
    "###THIS WORKED BUT I SHOULD HAVE REMOVED STOP WORDS FIRST. SEE BELOW###\n",
    "#This should make each word_tokenized story in the article_text_words column of the dataframe\n",
    "#into a list of trigrams, and then put that list as a new column in the dataframe.\n",
    "\n",
    "article_text_trigrams_list=[]\n",
    "for article in df_9_companies_prep['article_text_words']:\n",
    "    trigrams = list(ngrams(article, 3))\n",
    "    article_text_trigrams_list.append(trigrams)\n",
    "df_9_companies_prep['article_text_trigrams']=article_text_trigrams_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_clean</th>\n",
       "      <th>article_text_words</th>\n",
       "      <th>article_text_trigrams</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>September 15, 2016 at 7:30 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>New Data Presented at ECTRIMS Reinforce Effica...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>new analysis of “ no evidence of disease activ...</td>\n",
       "      <td>[new, analysis, of, “, no, evidence, of, disea...</td>\n",
       "      <td>[(new, analysis, of), (analysis, of, “), (of, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1</td>\n",
       "      <td>July 5, 2016 at 8:00 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen and AbbVie’s Once-Monthly ZINBRYTA™ (Da...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>significantly reduced multiple of disease acti...</td>\n",
       "      <td>[significantly, reduced, multiple, of, disease...</td>\n",
       "      <td>[(significantly, reduced, multiple), (reduced,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2</td>\n",
       "      <td>December 20, 2016 at 9:00 AM EST</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen to Present at the 35th Annual J.P. Morg...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>mass business wire biogen today that it will p...</td>\n",
       "      <td>[mass, business, wire, biogen, today, that, it...</td>\n",
       "      <td>[(mass, business, wire), (business, wire, biog...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>3</td>\n",
       "      <td>August 9, 2016 at 9:00 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen Announces Bioverativ as Name of New Hem...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>will focus on innovation for people living wit...</td>\n",
       "      <td>[will, focus, on, innovation, for, people, liv...</td>\n",
       "      <td>[(will, focus, on), (focus, on, innovation), (...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>4</td>\n",
       "      <td>December 21, 2016 at 8:00 AM EST</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen to Report Fourth Quarter and Year End 2...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>mass business wire biogen today it will report...</td>\n",
       "      <td>[mass, business, wire, biogen, today, it, will...</td>\n",
       "      <td>[(mass, business, wire), (business, wire, biog...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        article_date  \\\n",
       "0  September 15, 2016 at 7:30 AM EDT   \n",
       "1        July 5, 2016 at 8:00 AM EDT   \n",
       "2   December 20, 2016 at 9:00 AM EST   \n",
       "3      August 9, 2016 at 9:00 AM EDT   \n",
       "4   December 21, 2016 at 8:00 AM EST   \n",
       "\n",
       "                                   article_link-href  \\\n",
       "0  https://investors.biogen.com/news-releases/new...   \n",
       "1  https://investors.biogen.com/news-releases/new...   \n",
       "2  https://investors.biogen.com/news-releases/new...   \n",
       "3  https://investors.biogen.com/news-releases/new...   \n",
       "4  https://investors.biogen.com/news-releases/new...   \n",
       "\n",
       "                                       article_title ticker  \\\n",
       "0  New Data Presented at ECTRIMS Reinforce Effica...   BIIB   \n",
       "1  Biogen and AbbVie’s Once-Monthly ZINBRYTA™ (Da...   BIIB   \n",
       "2  Biogen to Present at the 35th Annual J.P. Morg...   BIIB   \n",
       "3  Biogen Announces Bioverativ as Name of New Hem...   BIIB   \n",
       "4  Biogen to Report Fourth Quarter and Year End 2...   BIIB   \n",
       "\n",
       "                                  article_text_clean  \\\n",
       "0  new analysis of “ no evidence of disease activ...   \n",
       "1  significantly reduced multiple of disease acti...   \n",
       "2  mass business wire biogen today that it will p...   \n",
       "3  will focus on innovation for people living wit...   \n",
       "4  mass business wire biogen today it will report...   \n",
       "\n",
       "                                  article_text_words  \\\n",
       "0  [new, analysis, of, “, no, evidence, of, disea...   \n",
       "1  [significantly, reduced, multiple, of, disease...   \n",
       "2  [mass, business, wire, biogen, today, that, it...   \n",
       "3  [will, focus, on, innovation, for, people, liv...   \n",
       "4  [mass, business, wire, biogen, today, it, will...   \n",
       "\n",
       "                               article_text_trigrams  \n",
       "0  [(new, analysis, of), (analysis, of, “), (of, ...  \n",
       "1  [(significantly, reduced, multiple), (reduced,...  \n",
       "2  [(mass, business, wire), (business, wire, biog...  \n",
       "3  [(will, focus, on), (focus, on, innovation), (...  \n",
       "4  [(mass, business, wire), (business, wire, biog...  "
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_9_companies_prep.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [],
   "source": [
    "#looks like that worked. Pickle this dataframe. Save as df_9_companies_prep_trigrams.pickle,\n",
    "#to indicate the column of trigrams.\n",
    "with open('df_9_companies_prep_trigrams.pickle', 'wb') as to_write:\n",
    "    pickle.dump(df_9_companies_prep, to_write)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_clean</th>\n",
       "      <th>article_text_words</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>September 15, 2016 at 7:30 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>New Data Presented at ECTRIMS Reinforce Effica...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>new analysis of “ no evidence of disease activ...</td>\n",
       "      <td>[new, analysis, of, “, no, evidence, of, disea...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        article_date  \\\n",
       "0  September 15, 2016 at 7:30 AM EDT   \n",
       "\n",
       "                                   article_link-href  \\\n",
       "0  https://investors.biogen.com/news-releases/new...   \n",
       "\n",
       "                                       article_title ticker  \\\n",
       "0  New Data Presented at ECTRIMS Reinforce Effica...   BIIB   \n",
       "\n",
       "                                  article_text_clean  \\\n",
       "0  new analysis of “ no evidence of disease activ...   \n",
       "\n",
       "                                  article_text_words  \n",
       "0  [new, analysis, of, “, no, evidence, of, disea...  "
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#What I should have done was to remove the stop words after word_tokenizer, but before\n",
    "#making the trigrams. Let's drop the trigrams column and try this again.\n",
    "df_9_companies_prep.drop(columns=['article_text_trigrams'], inplace=True)\n",
    "df_9_companies_prep.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "179\n",
      "186\n"
     ]
    }
   ],
   "source": [
    "#add words ('press', 'release', 'back', 'view', 'printer', 'friendly', 'version') to stopwords list\n",
    "#need to use .extend(), NOT .append() to add more than one word!!\n",
    "stop=stopwords.words('english')\n",
    "print(len(stop))\n",
    "extras=['press', 'release', 'back', 'view', 'printer', 'friendly', 'version']\n",
    "stop.extend(extras)\n",
    "print(len(stop))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [],
   "source": [
    "#print(stop)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_9_companies_prep['article_text_nostop']=(df_9_companies_prep['article_text_words']).apply(lambda x: [item for item in x if item not in stop])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_clean</th>\n",
       "      <th>article_text_words</th>\n",
       "      <th>article_text_nostop</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>September 15, 2016 at 7:30 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>New Data Presented at ECTRIMS Reinforce Effica...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>new analysis of “ no evidence of disease activ...</td>\n",
       "      <td>[new, analysis, of, “, no, evidence, of, disea...</td>\n",
       "      <td>[new, analysis, “, evidence, disease, activity...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1</td>\n",
       "      <td>July 5, 2016 at 8:00 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen and AbbVie’s Once-Monthly ZINBRYTA™ (Da...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>significantly reduced multiple of disease acti...</td>\n",
       "      <td>[significantly, reduced, multiple, of, disease...</td>\n",
       "      <td>[significantly, reduced, multiple, disease, ac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2</td>\n",
       "      <td>December 20, 2016 at 9:00 AM EST</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen to Present at the 35th Annual J.P. Morg...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>mass business wire biogen today that it will p...</td>\n",
       "      <td>[mass, business, wire, biogen, today, that, it...</td>\n",
       "      <td>[mass, business, wire, biogen, today, present,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>3</td>\n",
       "      <td>August 9, 2016 at 9:00 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen Announces Bioverativ as Name of New Hem...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>will focus on innovation for people living wit...</td>\n",
       "      <td>[will, focus, on, innovation, for, people, liv...</td>\n",
       "      <td>[focus, innovation, people, living, hemophilia...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>4</td>\n",
       "      <td>December 21, 2016 at 8:00 AM EST</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen to Report Fourth Quarter and Year End 2...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>mass business wire biogen today it will report...</td>\n",
       "      <td>[mass, business, wire, biogen, today, it, will...</td>\n",
       "      <td>[mass, business, wire, biogen, today, report, ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        article_date  \\\n",
       "0  September 15, 2016 at 7:30 AM EDT   \n",
       "1        July 5, 2016 at 8:00 AM EDT   \n",
       "2   December 20, 2016 at 9:00 AM EST   \n",
       "3      August 9, 2016 at 9:00 AM EDT   \n",
       "4   December 21, 2016 at 8:00 AM EST   \n",
       "\n",
       "                                   article_link-href  \\\n",
       "0  https://investors.biogen.com/news-releases/new...   \n",
       "1  https://investors.biogen.com/news-releases/new...   \n",
       "2  https://investors.biogen.com/news-releases/new...   \n",
       "3  https://investors.biogen.com/news-releases/new...   \n",
       "4  https://investors.biogen.com/news-releases/new...   \n",
       "\n",
       "                                       article_title ticker  \\\n",
       "0  New Data Presented at ECTRIMS Reinforce Effica...   BIIB   \n",
       "1  Biogen and AbbVie’s Once-Monthly ZINBRYTA™ (Da...   BIIB   \n",
       "2  Biogen to Present at the 35th Annual J.P. Morg...   BIIB   \n",
       "3  Biogen Announces Bioverativ as Name of New Hem...   BIIB   \n",
       "4  Biogen to Report Fourth Quarter and Year End 2...   BIIB   \n",
       "\n",
       "                                  article_text_clean  \\\n",
       "0  new analysis of “ no evidence of disease activ...   \n",
       "1  significantly reduced multiple of disease acti...   \n",
       "2  mass business wire biogen today that it will p...   \n",
       "3  will focus on innovation for people living wit...   \n",
       "4  mass business wire biogen today it will report...   \n",
       "\n",
       "                                  article_text_words  \\\n",
       "0  [new, analysis, of, “, no, evidence, of, disea...   \n",
       "1  [significantly, reduced, multiple, of, disease...   \n",
       "2  [mass, business, wire, biogen, today, that, it...   \n",
       "3  [will, focus, on, innovation, for, people, liv...   \n",
       "4  [mass, business, wire, biogen, today, it, will...   \n",
       "\n",
       "                                 article_text_nostop  \n",
       "0  [new, analysis, “, evidence, disease, activity...  \n",
       "1  [significantly, reduced, multiple, disease, ac...  \n",
       "2  [mass, business, wire, biogen, today, present,...  \n",
       "3  [focus, innovation, people, living, hemophilia...  \n",
       "4  [mass, business, wire, biogen, today, report, ...  "
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_9_companies_prep.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_words</th>\n",
       "      <th>article_text_nostop</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>September 15, 2016 at 7:30 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>New Data Presented at ECTRIMS Reinforce Effica...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>[new, analysis, of, “, no, evidence, of, disea...</td>\n",
       "      <td>[new, analysis, “, evidence, disease, activity...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        article_date  \\\n",
       "0  September 15, 2016 at 7:30 AM EDT   \n",
       "\n",
       "                                   article_link-href  \\\n",
       "0  https://investors.biogen.com/news-releases/new...   \n",
       "\n",
       "                                       article_title ticker  \\\n",
       "0  New Data Presented at ECTRIMS Reinforce Effica...   BIIB   \n",
       "\n",
       "                                  article_text_words  \\\n",
       "0  [new, analysis, of, “, no, evidence, of, disea...   \n",
       "\n",
       "                                 article_text_nostop  \n",
       "0  [new, analysis, “, evidence, disease, activity...  "
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "###NO TRIGRAMS\n",
    "#OK! That worked. Let's make trigrams, but first drop the article_text_clean column to save space\n",
    "df_9_companies_prep.drop(columns=['article_text_clean'], inplace=True)\n",
    "df_9_companies_prep.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [],
   "source": [
    "#pickle this dataframe\n",
    "with open('df_9_companies_prep_nostop.pickle', 'wb') as to_write:\n",
    "    pickle.dump(df_9_companies_prep, to_write)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Now make the trigrams. Use the code from above, as it worked.\n",
    "article_text_trigrams_list=[]\n",
    "for article in df_9_companies_prep['article_text_nostop']:\n",
    "    trigrams = list(ngrams(article, 3))\n",
    "    article_text_trigrams_list.append(trigrams)\n",
    "df_9_companies_prep['article_text_trigrams']=article_text_trigrams_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_words</th>\n",
       "      <th>article_text_nostop</th>\n",
       "      <th>article_text_trigrams</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>September 15, 2016 at 7:30 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>New Data Presented at ECTRIMS Reinforce Effica...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>[new, analysis, of, “, no, evidence, of, disea...</td>\n",
       "      <td>[new, analysis, “, evidence, disease, activity...</td>\n",
       "      <td>[(new, analysis, “), (analysis, “, evidence), ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        article_date  \\\n",
       "0  September 15, 2016 at 7:30 AM EDT   \n",
       "\n",
       "                                   article_link-href  \\\n",
       "0  https://investors.biogen.com/news-releases/new...   \n",
       "\n",
       "                                       article_title ticker  \\\n",
       "0  New Data Presented at ECTRIMS Reinforce Effica...   BIIB   \n",
       "\n",
       "                                  article_text_words  \\\n",
       "0  [new, analysis, of, “, no, evidence, of, disea...   \n",
       "\n",
       "                                 article_text_nostop  \\\n",
       "0  [new, analysis, “, evidence, disease, activity...   \n",
       "\n",
       "                               article_text_trigrams  \n",
       "0  [(new, analysis, “), (analysis, “, evidence), ...  "
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_9_companies_prep.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [],
   "source": [
    "#pickle this dataframe. I put the old trigrams pickle file in the trash.\n",
    "with open('df_9_companies_prep_trigrams.pickle', 'wb') as to_write:\n",
    "    pickle.dump(df_9_companies_prep, to_write)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#next step is to lemmatize"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: cython in /Library/Frameworks/Python.framework/Versions/3.8/lib/python3.8/site-packages (0.29.22)\r\n"
     ]
    }
   ],
   "source": [
    "!pip install cython"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting package metadata (current_repodata.json): done\n",
      "Solving environment: done\n",
      "\n",
      "# All requested packages already installed.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "!conda install -c conda-forge gensim"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "metadata": {},
   "outputs": [],
   "source": [
    "###GENSIM DID NOT WORK\n",
    "import gensim\n",
    "import gensim.corpora as corpora\n",
    "from gensim.utils import simple_preprocess\n",
    "from gensim.utils import lemmatize\n",
    "#It's telling me I need to install the pattern library. When I try to do that via pip \n",
    "#from the command line, I get an error: ERROR: Could not find a version that satisfies the requirement mysqlclient (from pattern)\n",
    "#ERROR: No matching distribution found for mysqlclient\n",
    "#I'm reading on https://github.com/clips/pattern that pattern supports python 3.6, \n",
    "#since I'm running 3.8, maybe it won't work with 3.8. Also Word2Vec is not working."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "from nltk.stem import WordNetLemmatizer\n",
    "wnl=WordNetLemmatizer()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package wordnet to\n",
      "[nltk_data]     /Users/amysillman/nltk_data...\n",
      "[nltk_data]   Package wordnet is already up-to-date!\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nltk.download('wordnet')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dog\n"
     ]
    }
   ],
   "source": [
    "print(wnl.lemmatize('dogs'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "metadata": {},
   "outputs": [],
   "source": [
    "#I'm not sure it will lemmatize on the trigrams. I guess they're individual tokens, so \n",
    "#it should be able to.\n",
    "\n",
    "def lemmatize_text(text):\n",
    "    lemmatizer = WordNetLemmatizer()\n",
    "    return [lemmatizer.lemmatize(w) for w in text]\n",
    "\n",
    "df_9_companies_prep['words_lemmatized']=(df_9_companies_prep['article_text_nostop']).apply(lemmatize_text)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_words</th>\n",
       "      <th>article_text_nostop</th>\n",
       "      <th>article_text_trigrams</th>\n",
       "      <th>words_lemmatized</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>September 15, 2016 at 7:30 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>New Data Presented at ECTRIMS Reinforce Effica...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>[new, analysis, of, “, no, evidence, of, disea...</td>\n",
       "      <td>[new, analysis, “, evidence, disease, activity...</td>\n",
       "      <td>[(new, analysis, “), (analysis, “, evidence), ...</td>\n",
       "      <td>[new, analysis, “, evidence, disease, activity...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1</td>\n",
       "      <td>July 5, 2016 at 8:00 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen and AbbVie’s Once-Monthly ZINBRYTA™ (Da...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>[significantly, reduced, multiple, of, disease...</td>\n",
       "      <td>[significantly, reduced, multiple, disease, ac...</td>\n",
       "      <td>[(significantly, reduced, multiple), (reduced,...</td>\n",
       "      <td>[significantly, reduced, multiple, disease, ac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2</td>\n",
       "      <td>December 20, 2016 at 9:00 AM EST</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen to Present at the 35th Annual J.P. Morg...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>[mass, business, wire, biogen, today, that, it...</td>\n",
       "      <td>[mass, business, wire, biogen, today, present,...</td>\n",
       "      <td>[(mass, business, wire), (business, wire, biog...</td>\n",
       "      <td>[mass, business, wire, biogen, today, present,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>3</td>\n",
       "      <td>August 9, 2016 at 9:00 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen Announces Bioverativ as Name of New Hem...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>[will, focus, on, innovation, for, people, liv...</td>\n",
       "      <td>[focus, innovation, people, living, hemophilia...</td>\n",
       "      <td>[(focus, innovation, people), (innovation, peo...</td>\n",
       "      <td>[focus, innovation, people, living, hemophilia...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>4</td>\n",
       "      <td>December 21, 2016 at 8:00 AM EST</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen to Report Fourth Quarter and Year End 2...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>[mass, business, wire, biogen, today, it, will...</td>\n",
       "      <td>[mass, business, wire, biogen, today, report, ...</td>\n",
       "      <td>[(mass, business, wire), (business, wire, biog...</td>\n",
       "      <td>[mass, business, wire, biogen, today, report, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>5</td>\n",
       "      <td>April 29, 2016 at 7:39 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen and AbbVie Receive Positive Opinion fro...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>[positive, benefit, risk, profile, of, by, lar...</td>\n",
       "      <td>[positive, benefit, risk, profile, large, head...</td>\n",
       "      <td>[(positive, benefit, risk), (benefit, risk, pr...</td>\n",
       "      <td>[positive, benefit, risk, profile, large, head...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>6</td>\n",
       "      <td>April 27, 2016 at 9:15 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen Appoints Michael Ehlers Executive Vice ...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>[will, lead, company, ’, s, to, create, mass, ...</td>\n",
       "      <td>[lead, company, ’, create, mass, business, wir...</td>\n",
       "      <td>[(lead, company, ’), (company, ’, create), (’,...</td>\n",
       "      <td>[lead, company, ’, create, mass, business, wir...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>7</td>\n",
       "      <td>June 20, 2016 at 4:01 PM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Biogen to Report Second Quarter 2016 Financial...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>[mass, business, wire, biogen, today, it, will...</td>\n",
       "      <td>[mass, business, wire, biogen, today, report, ...</td>\n",
       "      <td>[(mass, business, wire), (business, wire, biog...</td>\n",
       "      <td>[mass, business, wire, biogen, today, report, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>8</td>\n",
       "      <td>May 13, 2016 at 2:47 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Alprolix® (rFIXFc) Approved in the EU for the ...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>[first, fusion, therapy, for, b, in, the, eu, ...</td>\n",
       "      <td>[first, fusion, therapy, b, eu, provide, exten...</td>\n",
       "      <td>[(first, fusion, therapy), (fusion, therapy, b...</td>\n",
       "      <td>[first, fusion, therapy, b, eu, provide, exten...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>9</td>\n",
       "      <td>April 29, 2016 at 11:00 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>Adam Koppel, Executive Vice President, Strateg...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>[mass, –, biogen, today, that, m, d, d, execut...</td>\n",
       "      <td>[mass, –, biogen, today, executive, vice, pres...</td>\n",
       "      <td>[(mass, –, biogen), (–, biogen, today), (bioge...</td>\n",
       "      <td>[mass, –, biogen, today, executive, vice, pres...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        article_date  \\\n",
       "0  September 15, 2016 at 7:30 AM EDT   \n",
       "1        July 5, 2016 at 8:00 AM EDT   \n",
       "2   December 20, 2016 at 9:00 AM EST   \n",
       "3      August 9, 2016 at 9:00 AM EDT   \n",
       "4   December 21, 2016 at 8:00 AM EST   \n",
       "5      April 29, 2016 at 7:39 AM EDT   \n",
       "6      April 27, 2016 at 9:15 AM EDT   \n",
       "7       June 20, 2016 at 4:01 PM EDT   \n",
       "8        May 13, 2016 at 2:47 AM EDT   \n",
       "9     April 29, 2016 at 11:00 AM EDT   \n",
       "\n",
       "                                   article_link-href  \\\n",
       "0  https://investors.biogen.com/news-releases/new...   \n",
       "1  https://investors.biogen.com/news-releases/new...   \n",
       "2  https://investors.biogen.com/news-releases/new...   \n",
       "3  https://investors.biogen.com/news-releases/new...   \n",
       "4  https://investors.biogen.com/news-releases/new...   \n",
       "5  https://investors.biogen.com/news-releases/new...   \n",
       "6  https://investors.biogen.com/news-releases/new...   \n",
       "7  https://investors.biogen.com/news-releases/new...   \n",
       "8  https://investors.biogen.com/news-releases/new...   \n",
       "9  https://investors.biogen.com/news-releases/new...   \n",
       "\n",
       "                                       article_title ticker  \\\n",
       "0  New Data Presented at ECTRIMS Reinforce Effica...   BIIB   \n",
       "1  Biogen and AbbVie’s Once-Monthly ZINBRYTA™ (Da...   BIIB   \n",
       "2  Biogen to Present at the 35th Annual J.P. Morg...   BIIB   \n",
       "3  Biogen Announces Bioverativ as Name of New Hem...   BIIB   \n",
       "4  Biogen to Report Fourth Quarter and Year End 2...   BIIB   \n",
       "5  Biogen and AbbVie Receive Positive Opinion fro...   BIIB   \n",
       "6  Biogen Appoints Michael Ehlers Executive Vice ...   BIIB   \n",
       "7  Biogen to Report Second Quarter 2016 Financial...   BIIB   \n",
       "8  Alprolix® (rFIXFc) Approved in the EU for the ...   BIIB   \n",
       "9  Adam Koppel, Executive Vice President, Strateg...   BIIB   \n",
       "\n",
       "                                  article_text_words  \\\n",
       "0  [new, analysis, of, “, no, evidence, of, disea...   \n",
       "1  [significantly, reduced, multiple, of, disease...   \n",
       "2  [mass, business, wire, biogen, today, that, it...   \n",
       "3  [will, focus, on, innovation, for, people, liv...   \n",
       "4  [mass, business, wire, biogen, today, it, will...   \n",
       "5  [positive, benefit, risk, profile, of, by, lar...   \n",
       "6  [will, lead, company, ’, s, to, create, mass, ...   \n",
       "7  [mass, business, wire, biogen, today, it, will...   \n",
       "8  [first, fusion, therapy, for, b, in, the, eu, ...   \n",
       "9  [mass, –, biogen, today, that, m, d, d, execut...   \n",
       "\n",
       "                                 article_text_nostop  \\\n",
       "0  [new, analysis, “, evidence, disease, activity...   \n",
       "1  [significantly, reduced, multiple, disease, ac...   \n",
       "2  [mass, business, wire, biogen, today, present,...   \n",
       "3  [focus, innovation, people, living, hemophilia...   \n",
       "4  [mass, business, wire, biogen, today, report, ...   \n",
       "5  [positive, benefit, risk, profile, large, head...   \n",
       "6  [lead, company, ’, create, mass, business, wir...   \n",
       "7  [mass, business, wire, biogen, today, report, ...   \n",
       "8  [first, fusion, therapy, b, eu, provide, exten...   \n",
       "9  [mass, –, biogen, today, executive, vice, pres...   \n",
       "\n",
       "                               article_text_trigrams  \\\n",
       "0  [(new, analysis, “), (analysis, “, evidence), ...   \n",
       "1  [(significantly, reduced, multiple), (reduced,...   \n",
       "2  [(mass, business, wire), (business, wire, biog...   \n",
       "3  [(focus, innovation, people), (innovation, peo...   \n",
       "4  [(mass, business, wire), (business, wire, biog...   \n",
       "5  [(positive, benefit, risk), (benefit, risk, pr...   \n",
       "6  [(lead, company, ’), (company, ’, create), (’,...   \n",
       "7  [(mass, business, wire), (business, wire, biog...   \n",
       "8  [(first, fusion, therapy), (fusion, therapy, b...   \n",
       "9  [(mass, –, biogen), (–, biogen, today), (bioge...   \n",
       "\n",
       "                                    words_lemmatized  \n",
       "0  [new, analysis, “, evidence, disease, activity...  \n",
       "1  [significantly, reduced, multiple, disease, ac...  \n",
       "2  [mass, business, wire, biogen, today, present,...  \n",
       "3  [focus, innovation, people, living, hemophilia...  \n",
       "4  [mass, business, wire, biogen, today, report, ...  \n",
       "5  [positive, benefit, risk, profile, large, head...  \n",
       "6  [lead, company, ’, create, mass, business, wir...  \n",
       "7  [mass, business, wire, biogen, today, report, ...  \n",
       "8  [first, fusion, therapy, b, eu, provide, exten...  \n",
       "9  [mass, –, biogen, today, executive, vice, pres...  "
      ]
     },
     "execution_count": 93,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_9_companies_prep.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "metadata": {},
   "outputs": [],
   "source": [
    "#df_9_companies_prep.at[9, 'words_lemmatized']\n",
    "#I'm not sure it worked..."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "metadata": {},
   "outputs": [],
   "source": [
    "#next step is to vectorize. Do both tf-idf and cv. Might want to pickle dataframe \n",
    "#and then take off a couple columns.\n",
    "with open('df_9_companies_prep_lemmatized.pickle', 'wb') as to_write:\n",
    "    pickle.dump(df_9_companies_prep, to_write)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Load pickled dataframe from vectorize-topic modeling notebook\n",
    "import pickle\n",
    "with open('df_9_companies_prep_lemmatized.pickle', 'rb') as read_file:\n",
    "    df_9_companies_prep=pickle.load(read_file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_clean</th>\n",
       "      <th>article_text_words</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>Apr 01, 2019</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Novartis adds clinical and preclinical anti-in...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>acquisition will give one clinical and two pre...</td>\n",
       "      <td>[acquisition, will, give, one, clinical, and, ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   article_date                                  article_link-href  \\\n",
       "0  Apr 01, 2019  https://www.novartis.com/news/media-releases/n...   \n",
       "\n",
       "                                       article_title ticker  \\\n",
       "0  Novartis adds clinical and preclinical anti-in...    NVS   \n",
       "\n",
       "                                  article_text_clean  \\\n",
       "0  acquisition will give one clinical and two pre...   \n",
       "\n",
       "                                  article_text_words  \n",
       "0  [acquisition, will, give, one, clinical, and, ...  "
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "##OK RESTART HERE. WE'RE GOING TO TAKE OUT STOPWORDS\n",
    "df_4_companies_prep.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_nostop</th>\n",
       "      <th>words_lemmatized</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>September 15, 2016 at 7:30 AM EDT</td>\n",
       "      <td>https://investors.biogen.com/news-releases/new...</td>\n",
       "      <td>New Data Presented at ECTRIMS Reinforce Effica...</td>\n",
       "      <td>BIIB</td>\n",
       "      <td>[new, analysis, “, evidence, disease, activity...</td>\n",
       "      <td>[new, analysis, “, evidence, disease, activity...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        article_date  \\\n",
       "0  September 15, 2016 at 7:30 AM EDT   \n",
       "\n",
       "                                   article_link-href  \\\n",
       "0  https://investors.biogen.com/news-releases/new...   \n",
       "\n",
       "                                       article_title ticker  \\\n",
       "0  New Data Presented at ECTRIMS Reinforce Effica...   BIIB   \n",
       "\n",
       "                                 article_text_nostop  \\\n",
       "0  [new, analysis, “, evidence, disease, activity...   \n",
       "\n",
       "                                    words_lemmatized  \n",
       "0  [new, analysis, “, evidence, disease, activity...  "
      ]
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "###WE DIDN'T LEMMATIZE THIS TIME\n",
    "#need to drop a couple columns\n",
    "df_9_companies_prep.drop(columns=['article_text_words', 'article_text_trigrams'], inplace=True)\n",
    "df_9_companies_prep.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "#take out more stopwords. Company names, words from the forward-looking statements\n",
    "#put into the extras list and add to the stopwords below.\n",
    "extras=['catalyst', 'clovis', 'eli', 'lilly', 'rigel', 'sanofi', 'aventis', 'theravance', 'vertex', 'novartis', 'biogen',\n",
    "'press', 'release', 'back', 'view', 'printer', 'friendly', 'version', \n",
    "'exchange',\n",
    "'commission',\n",
    "'sec',\n",
    "'forward',\n",
    "'looking',\n",
    "'speak',\n",
    "'biogen',\n",
    "'obligation',\n",
    "'whether',\n",
    "'please',\n",
    "'visit',\n",
    "'biogen',\n",
    "'follow',\n",
    "'twitter',\n",
    "'biogen',\n",
    "'safe',\n",
    "'harbor',\n",
    "'forward',\n",
    "'looking',\n",
    "'potential',\n",
    "'safety',\n",
    "'forward',\n",
    "'looking',\n",
    "'may',\n",
    "'potential',\n",
    "'anticipate',\n",
    "'believe',\n",
    "'estimate',\n",
    "'expect',\n",
    "'intend',\n",
    "'may',\n",
    "'plan',\n",
    "'meaning',\n",
    "'place',\n",
    "'undue',\n",
    "'reliance',\n",
    "'could',\n",
    "'materially',\n",
    "'reflected',\n",
    "'uncertainty',\n",
    "'success',\n",
    "'commercialization',\n",
    "'may',\n",
    "'impacted',\n",
    "'acceptance',\n",
    "'community',\n",
    "'competition',\n",
    "'market',\n",
    "'marketing',\n",
    "'process',\n",
    "'occurrence',\n",
    "'safety',\n",
    "'availability',\n",
    "'reimbursement',\n",
    "'biogen',\n",
    "'failure',\n",
    "'obtain',\n",
    "'regulatory',\n",
    "'failure',\n",
    "'protect',\n",
    "'intellectual',\n",
    "'property',\n",
    "'proprietary',\n",
    "'product',\n",
    "'liability',\n",
    "'party',\n",
    "'risk',\n",
    "'section',\n",
    "'biogen',\n",
    "'annual',\n",
    "'quarterly',\n",
    "'report',\n",
    "'biogen',\n",
    "'exchange',\n",
    "'commission',\n",
    "'sec',\n",
    "'forward',\n",
    "'looking',\n",
    "'speak',\n",
    "'biogen',\n",
    "'obligation',\n",
    "'forward',\n",
    "'looking',\n",
    "'whether',\n",
    "'new',\n",
    "'information',\n",
    "'future',\n",
    "'otherwise',\n",
    "'global',\n",
    "'based',\n",
    "'company',\n",
    "'formed',\n",
    "'following',\n",
    "'separation',\n",
    "'company',\n",
    "'’',\n",
    "'mission',\n",
    "'use',\n",
    "'unique',\n",
    "'approach',\n",
    "'innovation',\n",
    "'develop',\n",
    "'market',\n",
    "'address',\n",
    "'world',\n",
    "'together',\n",
    "'wholly',\n",
    "'subsidiary',\n",
    "'information',\n",
    "'company',\n",
    "'portfolio',\n",
    "'please',\n",
    "'visit',\n",
    "'follow',\n",
    "'twitter',\n",
    "'page',\n",
    "'forward',\n",
    "'looking',\n",
    "'news',\n",
    "'may',\n",
    "'forward',\n",
    "'looking',\n",
    "'private',\n",
    "'litigation',\n",
    "'reform',\n",
    "'act',\n",
    "'believe',\n",
    "'expect',\n",
    "'anticipate',\n",
    "'forward',\n",
    "'looking',\n",
    "'subject',\n",
    "'materially',\n",
    "'include',\n",
    "'limited',\n",
    "'intellectual',\n",
    "'property',\n",
    "'competition',\n",
    "'inherent',\n",
    "'process',\n",
    "'litigation',\n",
    "'government',\n",
    "'action',\n",
    "'applicable',\n",
    "'industry',\n",
    "'information',\n",
    "'economic',\n",
    "'competitive',\n",
    "'governmental',\n",
    "'technological',\n",
    "'may',\n",
    "'affect',\n",
    "'set',\n",
    "'forth',\n",
    "'item',\n",
    "'risk',\n",
    "'annual',\n",
    "'report',\n",
    "'form',\n",
    "'exchange',\n",
    "'commission',\n",
    "'obligation',\n",
    "'publicly',\n",
    "'forward',\n",
    "'looking',\n",
    "'except',\n",
    "'law',\n",
    "'supplementary',\n",
    "'appendix',\n",
    "'thumbnail',\n",
    "'preview',\n",
    "'square',\n",
    "'small',\n",
    "'full',\n",
    "'size',\n",
    "'contact',\n",
    "'medium',\n",
    "'contact',\n",
    "'law',\n",
    "'public',\n",
    "'griffin',\n",
    "'investor',\n",
    "'contact',\n",
    "'biogen',\n",
    "'mike',\n",
    "'shea', '\"', 'year', 'york', 'ability', 'commercially', 'filing', 'commercial']\n",
    " "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "metadata": {
    "scrolled": false
   },
   "outputs": [],
   "source": [
    "#finding words in the forward looking statements to take out. Looked at:\n",
    "#df_9_companies_prep.at[0, 'words_lemmatized']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "179\n",
      "390\n"
     ]
    }
   ],
   "source": [
    "stop=stopwords.words('english')\n",
    "print(len(stop))\n",
    "#extras=['press', 'release', 'back', 'view', 'printer', 'friendly', 'version']\n",
    "#see above for additions to the stop words list\n",
    "stop.extend(extras)\n",
    "print(len(stop))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "#apply the stop words to the column article_text_words\n",
    "df_4_companies_prep['article_words_nostop']=(df_4_companies_prep['article_text_words']).apply(lambda x: [item for item in x if item not in stop])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_date</th>\n",
       "      <th>article_link-href</th>\n",
       "      <th>article_title</th>\n",
       "      <th>ticker</th>\n",
       "      <th>article_text_clean</th>\n",
       "      <th>article_text_words</th>\n",
       "      <th>article_words_nostop</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>Apr 01, 2019</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Novartis adds clinical and preclinical anti-in...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>acquisition will give one clinical and two pre...</td>\n",
       "      <td>[acquisition, will, give, one, clinical, and, ...</td>\n",
       "      <td>[acquisition, give, one, clinical, two, precli...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1</td>\n",
       "      <td>Jun 15, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Novartis' Cosentyx shows sustained improvement...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>® is the first and only inhibitor to show sust...</td>\n",
       "      <td>[®, is, the, first, and, only, inhibitor, to, ...</td>\n",
       "      <td>[®, first, inhibitor, show, sustained, spondyl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2</td>\n",
       "      <td>Jun 04, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Novartis landmark study of Tafinlar® + Mekinis...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>study is follow up to date of a and inhibitor ...</td>\n",
       "      <td>[study, is, follow, up, to, date, of, a, and, ...</td>\n",
       "      <td>[study, date, inhibitor, combination, therapy,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>3</td>\n",
       "      <td>Apr 30, 2019</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/s...</td>\n",
       "      <td>Sandoz enters agreement for proposed trastuzum...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>collaboration in phase development for human e...</td>\n",
       "      <td>[collaboration, in, phase, development, for, h...</td>\n",
       "      <td>[collaboration, phase, development, human, epi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>4</td>\n",
       "      <td>Jun 23, 2017</td>\n",
       "      <td>https://www.novartis.com/news/media-releases/n...</td>\n",
       "      <td>Novartis pivotal CTL019 6-month follow-up data...</td>\n",
       "      <td>NVS</td>\n",
       "      <td>of complete remission or with incomplete blood...</td>\n",
       "      <td>[of, complete, remission, or, with, incomplete...</td>\n",
       "      <td>[complete, remission, incomplete, blood, count...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   article_date                                  article_link-href  \\\n",
       "0  Apr 01, 2019  https://www.novartis.com/news/media-releases/n...   \n",
       "1  Jun 15, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "2  Jun 04, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "3  Apr 30, 2019  https://www.novartis.com/news/media-releases/s...   \n",
       "4  Jun 23, 2017  https://www.novartis.com/news/media-releases/n...   \n",
       "\n",
       "                                       article_title ticker  \\\n",
       "0  Novartis adds clinical and preclinical anti-in...    NVS   \n",
       "1  Novartis' Cosentyx shows sustained improvement...    NVS   \n",
       "2  Novartis landmark study of Tafinlar® + Mekinis...    NVS   \n",
       "3  Sandoz enters agreement for proposed trastuzum...    NVS   \n",
       "4  Novartis pivotal CTL019 6-month follow-up data...    NVS   \n",
       "\n",
       "                                  article_text_clean  \\\n",
       "0  acquisition will give one clinical and two pre...   \n",
       "1  ® is the first and only inhibitor to show sust...   \n",
       "2  study is follow up to date of a and inhibitor ...   \n",
       "3  collaboration in phase development for human e...   \n",
       "4  of complete remission or with incomplete blood...   \n",
       "\n",
       "                                  article_text_words  \\\n",
       "0  [acquisition, will, give, one, clinical, and, ...   \n",
       "1  [®, is, the, first, and, only, inhibitor, to, ...   \n",
       "2  [study, is, follow, up, to, date, of, a, and, ...   \n",
       "3  [collaboration, in, phase, development, for, h...   \n",
       "4  [of, complete, remission, or, with, incomplete...   \n",
       "\n",
       "                                article_words_nostop  \n",
       "0  [acquisition, give, one, clinical, two, precli...  \n",
       "1  [®, first, inhibitor, show, sustained, spondyl...  \n",
       "2  [study, date, inhibitor, combination, therapy,...  \n",
       "3  [collaboration, phase, development, human, epi...  \n",
       "4  [complete, remission, incomplete, blood, count...  "
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_4_companies_prep.head()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "#pickle this dataframe and use it in the vectorize-topic modeling next notebook\n",
    "with open('df_4_companies_prep_nostop.pickle', 'wb') as to_write:\n",
    "    pickle.dump(df_4_companies_prep, to_write)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#take out quotation marks\n",
    "df_9_companies_prep['article_text_lower_noq'] = df_9_companies_prep['article_text_lower'].str.strip(to_strip='\"')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#force into a string data type\n",
    "katniss['story_text']=katniss['story_text'].astype(str)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package words to\n",
      "[nltk_data]     /Users/amysillman/nltk_data...\n",
      "[nltk_data]   Unzipping corpora/words.zip.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'Io to the beach with my .'"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import nltk\n",
    "nltk.download('words')\n",
    "words = set(nltk.corpus.words.words())\n",
    "\n",
    "sent = \"Io andiamo to the beach with my amico.\"\n",
    "\" \".join(w for w in nltk.wordpunct_tokenize(sent) \\\n",
    "     if w.lower() in words or not w.isalpha())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
